Stock Events

Stock Events

NeuroSense Therapeutics (NRSN) Q3 2024 Earnings

30SepConfirmed

Q3 2023

Q1 2024

Q2 2024

Q3 2024

-0.35

-0.2

-0.05

0.1

Details

Expected EPS

-0.185

Actual EPS

-0.05

Surprise EPS

0.14

Surprise Percent

+72.97%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.05 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.